phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Myocardial Infarction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batchelor, WB; Califf, RM; Cantor, WJ; Davidian, M; DiBattiste, PM; Dillard, P; Gretler, D; Harrington, RA; Huang, Y; Larsen, RL; Mantell, RM; Ohman, EM; Sketch, MH; Tcheng, JE; Tolleson, TR; Zhang, D; Zidar, JP | 1 |
Chen, AB; Collen, D; Hopkins, A; Stump, DC; Topol, EJ | 1 |
1 trial(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Myocardial Infarction
Article | Year |
---|---|
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, an
Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 2002 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Myocardial Infarction
Article | Year |
---|---|
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.
Topics: Amino Acid Chloromethyl Ketones; Aprotinin; Blood Specimen Collection; Citrates; Citric Acid; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Myocardial Infarction; Tissue Plasminogen Activator | 1988 |